Φορτώνει......
Cancer immunotherapy using a bi-specific NK receptor- fusion protein that engages both T cells and tumor cells
T cell immunotherapy is a promising strategy to treat cancer. The aim of this study was to investigate a new approach to deliver selective T cell activation against tumor cells. We have developed a bi-specific fusion protein that recognizes tumor cells through an NK activating receptor NKG2D and sti...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2011
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3095211/ https://ncbi.nlm.nih.gov/pubmed/21282338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-3200 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|